A phase II study of active specific immunotherapy and5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma

Active specific immunotherapy, using vaccines with autologous tumour cells and BCG, significantly reduces the rate of tumour recurrence in stage II colon cancer patients, while no clinical benefit has yet been observed in stage III patients. Adjuvant treatment with 5-Fluorouracil/Leucovorin is now c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Baars, A, Claessen, A M E, Wagstaff, J, Giaccone, G, Scheper, R J, Meijer, S, Schakel, M J A G, Gall, H E, Meijer, C J L M, Vermorken, J B, Pinedo, H M, van den Eertwegh, A J M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2002
Soggetti:
Clinical
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2375342/
https://ncbi.nlm.nih.gov/pubmed/11953877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600254
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi